China's first anti-COVID-19 drugs, two monoclonal antibody medicines used for a combination therapy recently greenlighted by the China's National Medical Products Administration (NMPA), were developed in just under 20 months.
https://www.cctvplus.com/news/20211214/8247246.shtml#!language=1
Welcome to subscribe us on:
Facebook: https://www.facebook.com/NewsContent.CCTVPLUS
Twitter: https://twitter.com/CCTV_Plus
LinkedIn: https://www.linkedin.com/company/cctv-news-content
Video on Demand: www.cctvplus.com
If you are in demand of this video footage, please contact with our business development team via email: [email protected]
https://www.cctvplus.com/news/20211214/8247246.shtml#!language=1
Welcome to subscribe us on:
Facebook: https://www.facebook.com/NewsContent.CCTVPLUS
Twitter: https://twitter.com/CCTV_Plus
LinkedIn: https://www.linkedin.com/company/cctv-news-content
Video on Demand: www.cctvplus.com
If you are in demand of this video footage, please contact with our business development team via email: [email protected]
- Category
- Health
Be the first to comment